Thrivent Financial for Lutherans Sells 51,825 Shares of Danaher Co. (NYSE:DHR)

Thrivent Financial for Lutherans cut its stake in shares of Danaher Co. (NYSE:DHRFree Report) by 8.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 582,706 shares of the conglomerate’s stock after selling 51,825 shares during the period. Thrivent Financial for Lutherans’ holdings in Danaher were worth $162,003,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in DHR. CarsonAllaria Wealth Management Ltd. acquired a new stake in Danaher during the 2nd quarter worth approximately $25,000. nVerses Capital LLC acquired a new stake in shares of Danaher during the second quarter worth $25,000. MFA Wealth Advisors LLC bought a new stake in shares of Danaher in the second quarter valued at about $51,000. Financial Connections Group Inc. acquired a new position in shares of Danaher in the second quarter valued at about $51,000. Finally, Western Pacific Wealth Management LP bought a new position in Danaher during the first quarter worth about $55,000. Institutional investors own 79.05% of the company’s stock.

Insider Activity

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. This represents a 18.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on DHR shares. Barclays decreased their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research report on Thursday, October 31st. Wells Fargo & Company started coverage on Danaher in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price objective for the company. Bank of America increased their target price on Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a report on Wednesday, July 24th. Finally, Royal Bank of Canada dropped their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Check Out Our Latest Analysis on Danaher

Danaher Stock Performance

Shares of DHR stock opened at $230.50 on Friday. The firm has a market capitalization of $166.49 billion, a price-to-earnings ratio of 43.99, a PEG ratio of 4.24 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The business’s 50-day moving average price is $262.20 and its 200-day moving average price is $260.47. Danaher Co. has a 12 month low of $206.30 and a 12 month high of $281.70.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the company earned $2.02 EPS. The firm’s revenue was up 3.1% compared to the same quarter last year. Equities research analysts forecast that Danaher Co. will post 7.51 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.